11.53
price down icon3.76%   -0.45
after-market 시간 외 거래: 11.52 -0.010 -0.09%
loading
전일 마감가:
$11.98
열려 있는:
$11.79
하루 거래량:
154.44K
Relative Volume:
0.67
시가총액:
$380.59M
수익:
$65.42M
순이익/손실:
$-32.96M
주가수익비율:
-9.0787
EPS:
-1.27
순현금흐름:
$-19.87M
1주 성능:
-0.77%
1개월 성능:
-5.72%
6개월 성능:
+64.95%
1년 성능:
-15.47%
1일 변동 폭
Value
$11.50
$12.04
1주일 범위
Value
$11.26
$12.49
52주 변동 폭
Value
$5.45
$15.11

뉴로페이스 Stock (NPCE) Company Profile

Name
명칭
Neuropace Inc
Name
전화
(650) 237-2700
Name
주소
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Name
직원
184
Name
트위터
Name
다음 수익 날짜
2025-03-04
Name
최신 SEC 제출 서류
Name
NPCE's Discussions on Twitter

NPCE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
NPCE
Neuropace Inc
11.53 380.59M 65.42M -32.96M -19.87M -1.27
Medical Devices icon
ABT
Abbott Laboratories
132.60 224.65B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
104.24 151.13B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
381.36 139.34B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
83.45 107.01B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
75.11 44.25B 5.54B 4.18B 259.90M 7.00

뉴로페이스 Stock (NPCE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-21 개시 UBS Buy
2024-03-14 업그레이드 Wells Fargo Equal Weight → Overweight
2024-01-30 개시 Leerink Partners Outperform
2023-11-10 개시 Cantor Fitzgerald Overweight
2023-08-24 업그레이드 Morgan Stanley Underweight → Equal-Weight
2023-02-22 개시 Lake Street Buy
2022-04-06 개시 Wolfe Research Outperform
2022-01-19 다운그레이드 Wells Fargo Overweight → Equal Weight
2022-01-07 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2021-11-11 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-08-18 개시 Robert W. Baird Outperform
2021-05-17 개시 JP Morgan Overweight
2021-05-17 개시 Morgan Stanley Overweight
2021-05-17 개시 SVB Leerink Outperform
2021-05-17 개시 Wells Fargo Overweight
모두보기

뉴로페이스 주식(NPCE)의 최신 뉴스

pulisher
May 05, 2025

JPMorgan Chase & Co. Purchases 52,829 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat

May 05, 2025
pulisher
May 04, 2025

Nantahala Capital Management LLC Sells 45,817 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat

May 04, 2025
pulisher
May 02, 2025

Study: NeuroPace’s Technology Can Help Reduce Epileptic Seizures - Medical Product Outsourcing

May 02, 2025
pulisher
Apr 30, 2025

28,547 Shares in NeuroPace, Inc. (NASDAQ:NPCE) Purchased by Walleye Capital LLC - MarketBeat

Apr 30, 2025
pulisher
Apr 30, 2025

NeuroPace, Inc. (NASDAQ:NPCE) Shares Acquired by JPMorgan Chase & Co. - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Retail investors who hold 34% of NeuroPace, Inc. (NASDAQ:NPCE) gained 10%, institutions profited as well - simplywall.st

Apr 29, 2025
pulisher
Apr 28, 2025

Geode Capital Management LLC Has $3.62 Million Stock Holdings in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Apr 28, 2025
pulisher
Apr 24, 2025

Short Interest in NeuroPace, Inc. (NASDAQ:NPCE) Rises By 45.8% - MarketBeat

Apr 24, 2025
pulisher
Apr 20, 2025

NeuroPace, Inc. (NASDAQ:NPCE) Sees Significant Growth in Short Interest - Defense World

Apr 20, 2025
pulisher
Apr 15, 2025

NeuroPace Inc (NPCE) Trading Down 3.19% on Apr 15 - GuruFocus

Apr 15, 2025
pulisher
Apr 14, 2025

NeuroPace expects minimal tariff impact, maintains guidance By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

NeuroPace expects minimal impact of tariffs on its operations and financial results - MSN

Apr 14, 2025
pulisher
Apr 14, 2025

Neuropace Provides Update On Tariff Status - marketscreener.com

Apr 14, 2025
pulisher
Apr 14, 2025

NeuroPace Reports 'Minimal impact' From Trump Tariffs - marketscreener.com

Apr 14, 2025
pulisher
Apr 14, 2025

NeuroPace Expects Minimal Impact from Trade Tariffs - TipRanks

Apr 14, 2025
pulisher
Apr 14, 2025

NeuroPace expects minimal tariff impact, maintains guidance - Investing.com Australia

Apr 14, 2025
pulisher
Apr 14, 2025

NeuroPace Provides Update on Tariff Status - The Manila Times

Apr 14, 2025
pulisher
Apr 14, 2025

US Manufacturing Shield: NeuroPace Dodges Tariff Headwinds as Peers Struggle - Stock Titan

Apr 14, 2025
pulisher
Apr 14, 2025

NeuroPace stock target cut to $17 by Cantor Fitzgerald - Investing.com Australia

Apr 14, 2025
pulisher
Apr 13, 2025

Contrasting DIH Holding US (NASDAQ:DHAI) & NeuroPace (NASDAQ:NPCE) - Defense World

Apr 13, 2025
pulisher
Apr 11, 2025

What is Leerink Partnrs' Forecast for NeuroPace Q1 Earnings? - MarketBeat

Apr 11, 2025
pulisher
Apr 10, 2025

Cantor Fitzgerald cuts NeuroPace stock target to $17 By Investing.com - Investing.com Canada

Apr 10, 2025
pulisher
Apr 10, 2025

Cantor Fitzgerald cuts NeuroPace stock target to $17 - Investing.com

Apr 10, 2025
pulisher
Apr 08, 2025

NeuroPace reports 82% seizure reduction in epilepsy study By Investing.com - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

NeuroPace Reports Data From 3-year Post-Approval Study Of RNS System In Focal Epilepsy - Nasdaq

Apr 08, 2025
pulisher
Apr 08, 2025

NeuroPace reports 82% seizure reduction in epilepsy study - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

NeuroPace announces data from long-term post-approval study of RNS System - TipRanks

Apr 08, 2025
pulisher
Apr 08, 2025

NeuroPace Announces Data From a Long-Term Post-Approval - GlobeNewswire

Apr 08, 2025
pulisher
Apr 07, 2025

Q1 Earnings Estimate for NeuroPace Issued By Leerink Partnrs - Defense World

Apr 07, 2025
pulisher
Apr 06, 2025

NeuroPace, Inc. (NASDAQ:NPCE) Sees Large Growth in Short Interest - MarketBeat

Apr 06, 2025
pulisher
Apr 03, 2025

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting - The Manila Times

Apr 03, 2025
pulisher
Apr 03, 2025

Breakthrough Results: NeuroPace's Brain-Responsive Epilepsy Treatment Shows 3-Year Outcomes - Stock Titan

Apr 03, 2025
pulisher
Apr 02, 2025

NeuroPace refocuses product portfolio; reaffirms 2025 revenue guidance - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

NeuroPace to end SEEG product distribution, maintains 2025 revenue outlook By Investing.com - Investing.com Canada

Apr 02, 2025
pulisher
Apr 02, 2025

NeuroPace to End Stereo EEG Distribution Accord; 2025 Revenue Guidance Affirmed - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

NeuroPace to terminate distribution relationship for Seeg products - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

NeuroPace Shifts Focus to Core RNS System - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Neuropace Inc Maintaining 2025 Revenue Guidance - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

NeuroPace to end SEEG product distribution, maintains 2025 revenue outlook - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

NeuroPace Announces Refocusing of Product Portfolio - The Manila Times

Apr 02, 2025

뉴로페이스 (NPCE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_devices ZBH
$90.48
price down icon 11.62%
medical_devices PHG
$25.64
price up icon 0.20%
medical_devices STE
$224.30
price down icon 0.23%
$69.37
price down icon 1.64%
$80.27
price down icon 1.65%
medical_devices EW
$75.11
price down icon 0.71%
자본화:     |  볼륨(24시간):